A new and innovative breast cancer gene mutation clinical trial will take place in Adelaide.
The trial will use an osteoporosis drug on women who carry the BRCA gene mutation to reduce the risk of developing breast and ovarian cancer and the need of preventive surgery.
The Australian-based Breast Cancer Trials research organization says the trial will be more focused on prevention than treatment, they will release more information next week during a meeting in Adelaide.